DNA repair mechanisms and their clinical impact in glioblastoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Glioblastoma is a highly lethal brain cancer, often recurring despite standard treatments like surgery, radiation, and temozolomide.
• DNA repair mechanisms are a major contributor to glioblastoma's resistance to therapy and subsequent relapse.
• Identifying molecular targets within these repair pathways is crucial for developing more effective treatments.

Purpose of the Study:

• To review current understanding of DNA repair mechanisms in glioblastoma.
• To explore therapeutic strategies targeting DNA repair, including inhibitors and drug delivery across the blood-brain barrier.
• To discuss the role of genetic and epigenetic alterations in shaping DNA repair and their implications for personalized therapy.

Main Methods:

• Review of cellular systems and animal models used in glioblastoma DNA repair research.
• Summary of recent findings on DNA lesion removal pathways after ionizing radiation and temozolomide treatment.
• Analysis of current in vitro and clinical trials of DNA repair inhibitors.
• Examination of genetic and epigenetic factors influencing DNA repair.

Main Results:

• DNA repair pathways are central to glioblastoma resistance and relapse.
• Various therapeutic strategies targeting DNA repair are under investigation, facing challenges like blood-brain barrier penetration.
• Genetic and epigenetic alterations significantly influence glioblastoma's DNA repair capacity, offering avenues for personalized medicine.

Conclusions:

• A deeper understanding of glioblastoma DNA repair mechanisms is vital for therapeutic advancement.
• Targeting DNA repair, coupled with strategies to improve drug delivery and consider genetic/epigenetic profiles, holds promise for personalized glioblastoma treatment.